|Articles|August 17, 2010
Today's Daily Dose: Immune-mediated hemolytic anemia
Cautions about implementing immune suppression in patients with this disease.
Advertisement
Untitled Document
“The inability to identify an underlying cause for IMHA means that immune suppression remains the mainstay treatment. Concerns about potential negative effects of this immune suppression exist, especially if an occult underlying infectious cause of IMHA was missed during the diagnostic work-up.”
Advertisement
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on dvm360
1
Key takeaways: Practical approaches to canine lymphoma diagnosis and management
2
Thailand makes history with nation's first cat pacemaker surgery
3
FDA conditionally approves topical drug for cattle to prevent and treat New World screwworm
4
Practical ophthalmology for senior pets
5
